About Yann Tan

Yann Chong Tan is the Founder & CEO of Nuevocor, a Singapore-headquartered biotechnology company that develops gene therapies and mechanobiology-centered treatments for cardiomyopathies. He led the company through a $24 million oversubscribed Series A round in 2021 and a $45 million Series B round in May 2025. Tan is recognized for focusing on rare genetic heart diseases and transitioning Nuevocor from preclinical to IND-stage.

Resources Pricing

Resources

Join freeJoin for free Free · no credit card

Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

AI-scored pitch deck
Matched investor list
Personalized outreach drafts

Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓

Library
Articles
Pitch Decks
Videos
Shorts
Profiles
Visuals
Questions
Ask

All
Seed & Pre-Seed
Series A & B
Fintech
SaaS & Dev Tools
Consumer & Social
Marketplace & Frontier
Mistakes to Avoid
Checklist
How to Send
Design
Length
Order
Storytelling
Investor Q&A
One-Pager
Email Templates
Data Room
Investor Update
Term Sheet
SAFE vs Priced
Due Diligence
Timeline
Metrics
Valuation
Cap Table
Pipeline
Board
Objections
References
Closing
Bridge Round
Down Round
Secondary Sale
Investor Rejection
First Meeting
Second Meeting
Partner Meeting
Post-Mortem
Update Cadence
Angel Round
Option Pool Shuffle
Fundraise Pause
Vetting VCs
First 90 Days
First Board Meeting
Reference Calls
NDA Template
Bylaws Template

LibraryPitch Deck Examples

Slide-by-slide guide

Library
Articles
Pitch Decks
Videos
Shorts
Profiles
Visuals
Questions
Ask

LibraryArticles

•By Alejandro Cremades

Yann Tan, Founder of Nuevocor

About Yann Tan

Yann Tan at a glance

More founders in Singapore (44)

Browse related founder lists (6)